Netherlands Neurology Devices Market Opportunities 2031

Netherlands Neurology Devices Market Opportunities 2031

Segments - Netherlands Neurology Devices Market by Type Of Devices (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices [Interventional/Surgical Simulators, Neurothrombectomy Devices, Carotid Artery Stents, Embolic Coils, and Support Devices], Neurosurgery Devices [Neuroendoscopes, Stereotactic Systems, Aneurysm Clips, and Other Neurosurgery Devices], Neurostimulation Devices [Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Other Neurostimulation Devices], and Other Type of Devices), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-2346 | 4.9 Rating | 83 Reviews | 183 Pages | Format : PDF Excel PPT

Report Description


Netherlands Neurology Devices Market Outlook 2031:

The Netherlands neurology devices market size was valued at USD 33 Million in 2022 and is projected to reach USD 48.62 Million by 2031, expanding at a CAGR of 4.4% during the forecast period 2023 - 2031. The growth of the market is attributed to the increasing incidents of neurology disorders.

Netherlands Neurology Devices Market Outlook

Neurological devices help to restore hearing and sight and provide increased function for individuals with congenital limb differences. It deals with disorder of the nervous system, which majorly comprise in brain, blood vessels, and muscles. More than 600 neurological disorders have been found in humans, which includes epilepsy, arteriovenous malformations, brain tumor, multiple sclerosis, aneurysms, and ischemic stroke.

  • Rising research & development (R&D) expenditure in the field of neurotherapy is anticipated to propel the growth of the market.
  • Growing investment by private players is expected to boost the market growth.
  • Implementation of stringent government regulations toward the approval of neurology devices can hamper the market growth.
  • Introduction of new products and innovations in neurology devices is estimated to provide lucrative opportunities for the market expansion.

Scope of the Neurology Devices Market Report

The report on the Netherlands neurology devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Netherlands neurology devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Type Of Devices (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices [Interventional/Surgical Simulators, Neurothrombectomy Devices, Carotid Artery Stents, Embolic Coils, and Support Devices], Neurosurgery Devices [Neuroendoscopes, Stereotactic Systems, Aneurysm Clips, and Other Neurosurgery Devices], Neurostimulation Devices [Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Other Neurostimulation Devices], and Other Type of Devices)

Geographical Zone

The Netherlands

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

B.Braun Melsungen AG; Boston Scientific Corporation; Stryker Corporation; Medtronic PLC; and Abbott Laboratories

Netherlands Neurology Devices Market Segment Insights

Cerebrospinal Fluid Management Devices segment is anticipated to expand at a healthy CAGR

Based on type of devices, the market is divided into cerebrospinal fluid management devices, interventional neurology devices, neurosurgery devices, neurostimulation devices, and other type of devices. The interventional neurology devices segment is further segregated into interventional/surgical simulators, neurothrombectomy devices, carotid artery stents, embolic coils, and support devices.

Additionally, the neurosurgery devices segment is classified as neuroendoscopes, stereotactic systems, aneurysm clips, and other neurosurgery devices. The neurostimulation devices segment is sub-segmented into spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, and other neurostimulation devices.

The cerebrospinal fluid management devices segment is expected to grow at a rapid pace during the forecast period owing to usage of these devices for diagnosis of various neurological devices. However, the neurosurgery devices segment is anticipated to hold a key share of the market in the coming years on account of easy availability of neurological devices in hospital settings and preference among patients to visit hospitals for diagnosis and treatment of neurological devices.

Netherlands Neurology Devices Market Devices Type

Segments

The Netherlands neurology devices market has been segmented on the basis of

Types of devices

  • Cerebrospinal Fluid Management Devices
  • Interventional Neurology Devices
    • Interventional/Surgical Simulators
    • Neurothrombectomy Devices
    • Carotid Artery Stents
    • Embolic Coils
    • Support Devices
  • Neurosurgery Devices
    • Neuroendoscopes
    • Stereotactic Systems
    • Aneurysm Clips
    • Other Neurosurgery Devices
  • Neurostimulation Devices
    • Spinal Cord Stimulation Devices
    • Deep Brain Stimulation Devices
    • Sacral Nerve Stimulation Devices
    • Other Neurostimulation Devices
  • Other Type of Devices

Country

  • The Netherlands

Key Players

Competitive Landscape

Key players competing in the Netherlands neurology devices market are B. Braun Melsungen AG; Boston Scientific Corporation; Stryker Corporation; Medtronic PLC; and Abbott Laboratories.

In September 2021, Boston Scientific announced the completion of its acquisition of the Lumenis LTD., a privately-held global surgical business company, which develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA).

In September 2021, Medtronic PLC, the global leader in medical technology, announced a pilot program with Mpirik to address disparities in care associated with the prevention of sudden cardiac arrest (SCA), a condition in which the heart unexpectedly stops beating.

In July 2021, Stryker Corporation announced the acquisition of Gauss Surgical, a Menlo Park, California-based medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery.

Netherlands Neurology Devices Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurology Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Neurology Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Neurology Devices Market - Supply Chain
  4.5. Global Neurology Devices Market Forecast
     4.5.1. Neurology Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Neurology Devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Neurology Devices Market Absolute $ Opportunity
5. Global Neurology Devices Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Neurology Devices Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Neurology Devices Demand Share Forecast, 2019-2026
6. North America Neurology Devices Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Neurology Devices Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Neurology Devices Demand Share Forecast, 2019-2026
7. Latin America Neurology Devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Neurology Devices Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Neurology Devices Demand Share Forecast, 2019-2026
8. Europe Neurology Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Neurology Devices Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Neurology Devices Demand Share Forecast, 2019-2026
9. Asia Pacific Neurology Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Neurology Devices Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Neurology Devices Demand Share Forecast, 2019-2026
10. Middle East & Africa Neurology Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Neurology Devices Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Neurology Devices Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Neurology Devices Market: Market Share Analysis
  11.2. Neurology Devices Distributors and Customers
  11.3. Neurology Devices Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. B.Braun Melsungen AG
     11.4.2. Boston Scientific Corporation
     11.4.3. Stryker Corporation
     11.4.4. Medtronic PLC
     11.4.5. Abbott Laboratories

Methodology

Our Clients

General Mills
Honda Motor Co. Ltd.
General Electric
Nestle SA
Pfizer
Siemens Healthcare
Deloitte
sinopec